LC
NUVL

Lindbrook Capital’s Nuvalent NUVL Stock Holding History

Lindbrook Capital’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.14K Buy
16
+13
+433% +$1.02K ﹤0.01% 2429
2024
Q4 		$235 Sell
3
-5
-63% -$467 ﹤0.01% 2705
2024
Q3 		$818 Buy
+8
New +$664 ﹤0.01% 2549
2024
Q2 		– Sell
-75
Closed -$5.63K – 2818
2024
Q1 		$5.63K Buy
+75
New +$5.97K ﹤0.01% 1847

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lindbrook Capital's NUVL Position: Q1 2025 in Review

Lindbrook Capital increased its Nuvalent (NUVL) stake by 433% in Q1 2025, buying an estimated $1.02K and bringing the position to 16 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

Lindbrook Capital first reported a position in NUVL in Q1 2024 and has held it in 4 quarters since. The position peaked at $5.63K in Q1 2024. 205 funds tracked by Wall St. Rank hold NUVL as of Q1 2025.

  • Lindbrook Capital held 16 shares of Nuvalent worth $1.14K as of Q1 2025.
  • Lindbrook Capital bought 13 Nuvalent shares in Q1 2025, an estimated $1.02K.
  • Nuvalent made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2429 holding.
  • Lindbrook Capital first reported a position in Nuvalent in Q1 2024 and has held it in 4 quarters since.
  • Lindbrook Capital's Nuvalent position peaked at $5.63K in Q1 2024.
  • 205 funds tracked by Wall St. Rank held Nuvalent as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.